DeCode Locates Gene Linked to Arthritis
DeCode Genetics Inc. scientists mapped a gene linked to rheumatoid arthritis, a step that could aid development of medicines and diagnostic tests.
Rheumatoid arthritis affects about one out of 100 people in the industrialized world, DeCode and partner Roche Holding said. The debilitating disease strikes women more often than men.
The finding triggers an undisclosed payment to DeCode from Roche under a 1998 agreement, the companies said. Roche has two alliances with DeCode worth a combined $500 million to develop diagnostic tests and find genes linked to 12 major diseases.
DeCode shares rose $1.85, or 23%, to $9.90 on Nasdaq.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
